BARDA Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests The funding is for the firm's SARS-CoV-2, pan-coronavirus, and multiplex SARS-CoV-2, influenza, and respiratory syncytial virus tests, according to BARDA. T2 Biosystems Q1 Revenues Nearly Triple Product revenues were up 345 percent, as the firm increased US sepsis test utilization by 85 percent and sold four T2Dx instruments. TGen, Jumpcode Genomics Marrying NGS, CRISPR to Build a Better COVID-19 Test Premium As diagnostics firms develop a new wave of COVID-19 tests using next-gen sequencing, TGen researchers are also adding CRISPR-based sample prep to their kit. Federal Agencies Collaborate to Solicit Proposals for SARS-CoV-2 Testing Supply Chain Scale-up The collaborators are requesting submissions including budget proposals to scale all supporting components of diagnostic test manufacturing. Cue Health Ramping Up COVID-19 Test Production Following Positive Mayo Clinic Study, DoD Funding Premium The test uses isothermal nucleic acid amplification to return results in 20 minutes at the point of care, and demonstrated 98 percent agreement with PCR testing. Feb 2, 2021 Visby Medical Wins $12.3M BARDA Contract for Coronavirus, Flu Combo Test Jan 13, 2021 BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests Nov 18, 2020 FDA Grants Emergency Use Authorization to First At-Home COVID-19 Test From Lucira Health Nov 6, 2020 Mesa Biotech Awarded $13M in BARDA Funding for Coronavirus, Flu Combo Test Nov 2, 2020 Hologic Wins $119M Contract From US Government to Expand COVID-19 Test Capacity Oct 6, 2020 RAD-X Awards Six Phase 2 Contracts for COVID-19 Testing Sep 30, 2020 BARDA Exercises $10.5M Option on T2 Bio Contract Sep 24, 2020 BARDA Awards $5.4M to Luminex for Expanded Respiratory Panel With Coronavirus Target Sep 14, 2020 GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Sep 1, 2020 Immunexpress, Biocartis to Roll Out Sepsis Test in Europe Ahead of Planned US Launch Premium Aug 5, 2020 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition Jun 16, 2020 Immunexpress Nabs $599K BARDA Contract to Develop Sepsis Test for Coronavirus Patient Triage May 5, 2020 Tangen Biosciences Receives Additional $3.3M From BARDA May 4, 2020 Hologic Awarded $13M from BARDA to Develop Second Coronavirus Assay Apr 27, 2020 Merck, ISB Collaborating on COVID-19 Drug, Vaccine Target Discovery Apr 20, 2020 Tangen Biosciences Wins $696K BARDA Contract to Develop Point-of-Care Coronavirus MDx Test Apr 20, 2020 Vela Diagnostics Awarded BARDA Funding for COVID-19 Test Mar 31, 2020 Cue Health Awarded $13M BARDA Contract for POC Coronavirus Test Mar 31, 2020 Luminex Receives Second BARDA Contract for $642K to Develop Rapid SARS-CoV-2 Test Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.